Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag for Engraftment Post-HSCT in Bone Marrow Failure Diseases
NCT05466201Phase 3Completed
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Oct 2022
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eltrombopag in bone marrow failure (BMF), sponsored by First Affiliated Hospital of Soochow University. Started Oct 2022; status: completed.
02
Drugs
eltrombopag
03
Conditions
bone marrow failure (BMF)
Beyond the preview
Go deeper on NCT05466201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05466201.